Close Menu

Neisseria gonorrhoeae

The company is currently working on multiple infectious disease products, including a panel for sexually transmitted infections and one for SARS-CoV-2.

The PCR diagnostic device is a palm-size, single-use, disposable device that detects N. gonorrhoeae and determines if it's susceptible to an antibiotic.

The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said.

The Ithaca, New York-based firm has submitted its molecular diagnostic instrument along with a test to detect chlamydia, gonorrhea, and trichomonas.

FIND also announced support for projects from Axxin and DNC Dx for point-of-care detection of sexually transmitted infections.  

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service. 

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

The latest NYS Department of Health approval expands the company's CT/NG testing to samples from multiple relevant body sites.

NEW YORK (GenomeWeb) — In the hope of preventing gonorrhea from becoming the next antimicrobial-resistant "superbug," researchers at the University of California, Los Angeles have been awarded a two-year, $270,000 National Institutes of Health grant to validate a real-time PCR assay for drug resi

Cepheid this week released Xpert Norovirus as a CE IVD marked product in Europe.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.